EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus

Jens Luebeck, Alvin Wei Tian Ng, Patricia C Galipeau, Xiaohong Li, Carissa A Sanchez, Annalise C Katz-Summercorn, Hoon Kim, Sriganesh Jammula, Yudou He, Scott M Lippman, Roel G W Verhaak, Carlo C Maley und 8 weitere

Nature · 27.04.2023 · 616 (7958) · 798-805

DOI: 10.1038/s41586-023-05937-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature, online erschienen am 12.04.2023. Verfasst von Jens Luebeck und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Engineering, University of California at San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Barrett Esophagus, DNA, Esophageal Neoplasms. Die Arbeit wurde bisher 193-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Cancer Research UK, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncogene amplification on extrachromosomal DNA (ecDNA) drives the evolution of tumours and their resistance to treatment, and is associated with poor outcomes for patients with cancer 1–6 . At present, it is unclear whether ecDNA is a later manifestation of genomic instability, or whether it can be an early event in the transition from dysplasia to cancer. Here, to better understand the development of ecDNA, we analysed whole-genome sequencing (WGS) data from patients with oesophageal adenocarcinoma (EAC) or Barrett’s oesophagus. These data included 206 biopsies in Barrett’s oesophagus surveillance and EAC cohorts from Cambridge University. We also analysed WGS and histology data from biopsies that were collected across multiple regions at 2 time points from 80 patients in a case–control study at the Fred Hutchinson Cancer Center. In the Cambridge cohorts, the frequency of ecDNA increased between Barrett’s-oesophagus-associated early-stage (24%) and late-stage (43%) EAC, suggesting that ecDNA is formed during cancer progression. In the cohort from the Fred Hutchinson Cancer Center, 33% of patients who developed EAC had at least one oesophageal biopsy with ecDNA before or at the diagnosis of EAC. In biopsies that were collected before cancer diagnosis, higher levels of ecDNA were present in samples from patients who later developed EAC than in samples from those who did not. We found that ecDNAs contained diverse collections of oncogenes and immunomodulatory genes. Furthermore, ecDNAs showed increases in copy number and structural complexity at more advanced stages of disease. Our findings show that ecDNA can develop early in the transition from high-grade dysplasia to cancer, and that ecDNAs progressively form and evolve under positive selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaBarrett EsophagusDNAEsophageal NeoplasmsCarcinogenesisDisease ProgressionEarly Detection of CancerHumansCase-Control StudiesWhole Genome SequencingCohort StudiesBiopsyOncogenesImmunomodulationDNA Copy Number VariationsGene Amplification

Substanzen

DNA

Autor:innen und Institutionen

  • Department of Computer Science and Engineering, University of California at San Diego, La Jolla, CA, USA.
  • Bioinformatics and Systems Biology Graduate Program, University of California at San Diego, La Jolla, CA, USA.
  • Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge, UK.
  • Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Förderung

  • NCI NIH HHS
  • Cancer Research UK
  • NIEHS NIH HHS
  • Medical Research Council
  • NIGMS NIH HHS

Zitieren

APA

Luebeck, J., Ng, A. W. T., Galipeau, P. C., Li, X., Sanchez, C. A., Katz-Summercorn, A. C., Kim, H., Jammula, S., He, Y., Lippman, S. M., Verhaak, R. G. W., Maley, C. C., Alexandrov, L. B., Reid, B. J., Fitzgerald, R. C., Paulson, T. G., Chang, H. Y., Wu, S., Bafna, V., & Mischel, P. S. (2023). Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus. Nature, 616(7958), 798-805. https://doi.org/10.1038/s41586-023-05937-5

Vancouver

Luebeck J, Ng AWT, Galipeau PC, Li X, Sanchez CA, Katz-Summercorn AC, et al. Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus. Nature. 2023;616(7958):798-805. doi:10.1038/s41586-023-05937-5

BibTeX
@article{Luebeck2023,
  author = {Luebeck, Jens and Ng, Alvin Wei Tian and Galipeau, Patricia C and Li, Xiaohong and Sanchez, Carissa A and Katz-Summercorn, Annalise C and Kim, Hoon and Jammula, Sriganesh and He, Yudou and Lippman, Scott M and Verhaak, Roel G W and Maley, Carlo C and Alexandrov, Ludmil B and Reid, Brian J and Fitzgerald, Rebecca C and Paulson, Thomas G and Chang, Howard Y and Wu, Sihan and Bafna, Vineet and Mischel, Paul S},
  title = {Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus},
  journal = {Nature},
  year = {2023},
  volume = {616},
  number = {7958},
  pages = {798--805},
  doi = {10.1038/s41586-023-05937-5}
}
Kostenlos starten →